What's happening with the Medibank share price today?

Medibank made a commitment at the start of the pandemic that it would not profit from COVID-19.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Medibank Private Ltd (ASX: MPL) share price is slightly in the green in early morning trade on Thursday.

Shares in the S&P/ASX 200 Index (ASX: XJO) healthcare stock closed yesterday trading for $3.50. Shares are currently changing hands for $3.505, up 0.14%.

This comes after Australia's biggest health insurer updated the market on its ongoing COVID-19 support package and give-back program.

excited young female in business attire and wearing glasses is holding up $100 notes in both hands.

Image source: Getty Images

What did the ASX 200 health insurer report?

In an announcement unlikely to have a direct material impact on the Medibank share price today, the health insurer announced it would return another $125 million to its customers.

Medibank has now provided $1.15 billion in support to its customers since the start of the global pandemic in early 2020.

The company said its customers would receive funds directly in their bank accounts. The new round of support will be up to $91 for extras-only policies and up to $402 for hospital and extras policies.

Medibank and ahm customers can expect those funds by October.

The cash return is funded from additional COVID-19 permanent net claims savings. Management said it would not impact the insurer's operating earnings for H1 2023. This is why I don't expect the new round of support funds will drag on the Medicare share price.

Commenting on the support package, group executive Milosh Milisavljevic said, "We have now given back $1.15 billion to customers through our COVID-19 give-back program since the start of the pandemic."

Milisavljevic continued:

This year alone we have returned $408 million to customers through cash backs, premium increase deferrals and rolling over extras limits. At a time when people are really feeling the pinch of cost-of-living pressures, we know this extra cash in their pocket will be welcomed.

We made a commitment at the start of the pandemic that we would not profit from COVID-19, and we've stuck by that promise.

Clients holding an active hospital and/or extras policy at any time during the first half of 2023 will be eligible for some portion of the cash-back package.

Medibank share price snapshot

The Medibank share price has been a strong performer in 2023, up 21% year to date.

Motley Fool contributor Bernd Struben has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A stressed businessman sits next to his briefcase with his head in his hands, while the ASX boards behind him show shares crashing.
52-Week Lows

CSL's collapse deepens. Why this ASX giant can't find a floor

CSL shares hit a 9-year low as new demand concerns emerge.

Read more »

A group of people in a corporate setting do a collective high five.
Healthcare Shares

Prediction: CSL shares could surpass $265 in 2026

CSL shares are tumbling again on Wednesday. Here's what it'll take for the price to take a u-turn.

Read more »

A doctor appears shocked as he looks through binoculars on a blue background.
Healthcare Shares

Why are Cochlear shares down 36% today?

The medical device manufacturer has delivered a bitter pill for shareholders.

Read more »

Health professional working on his laptop.
Healthcare Shares

Are ASX healthcare shares the next to rally?

This sector has plenty of opportunity long term.

Read more »

a woman puts her fingers in her ears with a pained expression on her face with her eyes closed as though trying to block hearing bad news or an unpleasant loud noise.
Healthcare Shares

Cochlear cuts FY26 earnings outlook amid softer sales

Cochlear reduces its FY26 earnings guidance amid softer implant sales, ongoing challenges in key markets, and a focus on long-term…

Read more »

A man sits nervously at his computer with his mouth resting against his hands clasped in front of him as he stares at the screen of his computer on a home desk.
Healthcare Shares

EBOS Group trims FY26 earnings guidance as fuel costs bite

EBOS Group trims FY26 earnings guidance as elevated fuel costs weigh on its healthcare distribution businesses.

Read more »

Female scientist working in a laboratory.
Healthcare Shares

This ASX biotech stock could more than double Canaccord Genuity says

This company has more than one iron in the fire.

Read more »

A medical researcher wearing a white coat sits at her desk in a laboratory conducting a test.
Healthcare Shares

This ASX biotech's shares just hit a new 12-month high, up more than 700% over a year. Here's why

Good news has this company's shares on the up.

Read more »